Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings from A.M. Asemissen and co-authors in the area of cancer vaccines published
June 2nd, 2009
Scientists discuss in 'Vaccination strategies in patients with renal cell carcinoma' new findings in cancer. "Although new treatment options for patients with advanced renal cell cancer (RCC) have been developed within recent years, vaccination is still a promising emerging treatment option. An increasing number of tumor-associated antigens (TAA) available for RCC are currently used and analyzed for their efficacy for antigen-specific vaccine strategies," scientists writing in the journal Cancer Immunology, Immunotherapy report. "Recently, antigen-specific vaccination with dendritic cells in patients with metastatic RCC was shown to induce cytotoxic T cell...
Source: Cancer Weekly (2009-06-02)
|
